Emma Hapke, Daniel Rosenbaum
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Internal Family Systems (IFS) therapy, developed over four decades, offers evidence-based techniques to guide clients towards Self, fostering inner clarity and compassion. IFS provides a safe and healing map for
Richard Schwartz
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Psychedelic-assisted therapy field emphasizes establishing trust, safety, and reputability through professional guidelines, standards, and certification systems. Session discusses current developments in certification requirements and supportive infrastructure.
Brigadier General (Ret) Stephe…, Natalie Gukasyan, Shannon Carlin, Will Van Derveer
Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.
Manoj Doss discusses psychedelic impact on episodic memories, highlighting FLUX theory. Fred Barrett explores psychedelic therapy's potential for lasting shifts in psychological and cognitive flexibility across disorders.
Frederick Barrett, Manoj K. Doss
MDMA's therapeutic mechanism differs from classical psychedelics, showing potential for treating CNS disorders. Shulgin's 1970s research inspired exploration of modifying MDMA's structure and developing novel compounds for improved effects.
Matthew Baggott
Family involvement in psychedelic therapy can optimize outcomes and prevent problematic patterns. Ethical, neurobiological, and psychological aspects, along with clinical trial data, support the benefits of engaging family members.
Jennifer Danby
Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.
Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou
Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.
Ingmar Gorman, Erika Dyck, Tehseen Noorani
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.